530313 — Kimia Biosciences Balance Sheet
0.000.00%
- IN₹1.39bn
- IN₹1.73bn
- IN₹1.19bn
- 83
- 43
- 10
- 40
Annual balance sheet for Kimia Biosciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 11.8 | 15.8 | 2.41 | 1.48 | 2.06 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 425 | 310 | 328 | 290 | 383 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 718 | 731 | 827 | 614 | 753 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 340 | 351 | 342 | 324 | 309 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 1,067 | 1,095 | 1,213 | 1,000 | 1,112 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 509 | 618 | 764 | 694 | 818 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 882 | 946 | 1,159 | 996 | 1,012 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 184 | 149 | 54.6 | 3.31 | 99.7 |
| Total Liabilities & Shareholders' Equity | 1,067 | 1,095 | 1,213 | 1,000 | 1,112 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |